Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma
Open Access
- 4 March 2005
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (7) , 608-616
- https://doi.org/10.1038/sj.cgt.7700824
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanomaBiochimica et Biophysica Acta (BBA) - General Subjects, 2004
- In situ generation of pseudotyped retroviral progeny by adenovirus‐mediated transduction of tumor cells enhances the killing effect of HSV‐tk suicide gene therapy in vitro and in vivoThe Journal of Gene Medicine, 2004
- An investigation of adverse effects caused by the injection of high-dose TNFα-expressing adenovirus vector into established murine melanomaGene Therapy, 2003
- Tumor Necrosis Factor α-Gene Therapy for an Established Murine Melanoma Using RGB (Arg-Gly-Asp) Fiber-mutant Adenovirus VectorsJapanese Journal of Cancer Research, 2002
- Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinaseCancer Gene Therapy, 2002
- Liver Damage using Suicide Genes: A Model for Oval Cell ActivationThe American Journal of Pathology, 2000
- A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination with Escalating Doses of Ganciclovir in Patients with Cutaneous Metastatic Malignant MelanomaHuman Gene Therapy, 2000
- A Phase 1-2 Clinical Trial of Gene Therapy for Recurrent Glioblastoma Multiforme by Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene Followed by GanciclovirHuman Gene Therapy, 1999
- Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malignant MesotheliomaHuman Gene Therapy, 1998
- Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.Proceedings of the National Academy of Sciences, 1996